Floatz logo

Panobinostat

Leukemia, Myelomonocytic, Acute

Indiana UniversitySmall moleculePhase 2Dormant
B
56/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
41/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Leukemia, Myelomonocytic, Acute cohort.

Asset / SponsorPhaseRating
bi 6727
University of Alberta
Phase 1CC
ALLOGENEIC HUMAN UMBILICAL CORD BLOOD
First Affiliated Hospital Xi'an Jiaotong University
Phase 1CC
Recombinant Human Interleukin-2
First Affiliated Hospital Xi'an Jiaotong University
Phase 1CC
Xiap Antisense
Aegera Therapeutics
Phase 1/2NR

Same molecule, other indications

Panobinostat is also rated in:

Hodgkins lymphomaDormant
BB
Indicative ·
68 / 100
View asset →
Non-Small Cell Lung CancerDormant
BB
Indicative ·
66 / 100
View asset →
chronic lymphocytic leukemia/small lymphocytic lymphomaDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →